Table 2.
Characteristics of the Reviewed Articles
| Article | Year | Region | Disease | Sample # | Type of EQ-5D | Format |
|---|---|---|---|---|---|---|
| Algarni et al27 | 2020 | Makkah (Taif) | Musculoskeletal disorders | 153 | EQ-5D-3L | Self-report questionnaire |
| Alshayban and Joseph23 | 2020 | Eastern Province | Type 2 diabetes | 378 | Q-5D-5L | Interview |
| Althemery et al34 | 2020 | Riyadh | AF patients | 388 | Q-5D-5L | Paper |
| Elsalmawy et al33 | 2020 | Not specified | Patients using Teriparatide F | 364 | EQ-5D-5L | Self-report questionnaire |
| Abdelbasset et al28 | 2020 | Alkharj; | Chronic nonspecific low back pain | 60 | EQ-5D-3L | Self-report questionnaire |
| Alanazi30 | 2020 | Riyadh | Urinary tract infection | 131 | EQ-5D-3L | Self-report questionnaire |
| Almasri et al24 | 2020 | Jeddah | Type 2 diabetes | 339 | Q-5D-5L | Interview |
| Alghnam et al29 | 2020 | Riyadh | Blunt trauma | 249 | EQ-5D-5L | Interview |
| Gelhorn et al25 | 2020 | Jeddah, Riyadh, and Dammam | Type 2 diabetes | 310 | EQ-5D-5L | Self-report questionnaire |
| Bekairy et al35 | 2018 | Riyadh | No specific disease | 80 | EQ-5D-3L | Interview |
| Kokturk et al31 | 2018 | All | Chronic obstructive pulmonary disease | 206 | EQ-5D-3L | Self-report tool |
| Algahtani et al32 | 2017 | Jeddah | Multiple sclerosis | 292 | EQ-5D-5L | Interview |
| Al-Aboudi et al26 | 2015 | Riyadh | Type 2 diabetes | 75 | EQ-5D-3L | Self-report tool |